Diffuse Midline Glioma (DMG)
specific9
Centers
1
Active Trials
$7M
Cancer Funding
Top Centers for Diffuse Midline Glioma (DMG)(9)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | University of Michigan Rogel Cancer CenterAnn Arbor, MI NCI Comprehensive Active Research Program | 68.6 |
| 2 | NCI Comprehensive Active Research Program | 64.7 |
| 3 | Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive Active Research Program | 60.8 |
| 4 | Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive Active Research Program | 60.0 |
| 5 | NCI Comprehensive Active Research Program | 56.9 |
| 6 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program | 53.1 |
| 7 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 49.2 |
| 8 | UPMC Hillman Cancer CenterPittsburgh, PA NCI Comprehensive Active Research Program | 45.3 |
| 9 | NCI Clinical Active Research Program | 41.4 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →